MALAT1 and laryngotracheoesophageal cleft: High MALAT1 expression is linked to poor survival in LC patients [49,56], while low NEAT1 expression correlates with longer OS in LC [57] and improved OS in HNC patients treated with RT and chemotherapy (CTH) [48].